Thoracic Cancer

Article	Citations
Issue Information	233
Issue Information	63
Issue Information	56
Issue Information	44
Correction to “The Prevalence, Distribution, and Clinicopathological Features of Seven Lung Cancer Actionable Driver Mutations in Taiwan”	38
Issue Information	37
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab	36
Issue Information	35
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report	32
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma	30
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction	30
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report	30
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements	28
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche	27
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control	27
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer	27
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema	26
Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer	25
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1	25
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report	25
Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer	24
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation	23
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor	23
Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer	23
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China	23

PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC	22
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells	22
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report	22
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study	22
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report	22
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS	21
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035	21
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report	21
Safety and efficacy of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) for patients aged 80 years and older	20
Pathological characteristics of lung tumors in Sri Lanka 2017–2021	20
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring	20
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer	20
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway	20
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors	19
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases	19
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report	19
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize	19
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma	18
SLC34A2 promotes cell proliferation by activating STX17‐mediated autophagy in esophageal squamous cell carcinoma	18
Small‐cell lung cancer from the peripheral lung is frequently accompanied by emphysema and interstitial lung disease in the background	18
Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience	18
	18
Intrinsic resistance to ROS1 inhibition in a patient with CD74‐ROS1 mediated by AXL overexpression	18
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences	18
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study	18
Issue Information	18
Clinicopathological analysis of a superior sulcus tumor treated by salvage surgery after concurrent definitive chemoradiotherapy followed by durvalumab: A case report	18
Rare ashy dermatosis‐like hyperpigmentation associated with osimertinib	18
Implication of IZUMO2 in the cell‐in‐cell phenomenon: A potential therapeutic target for triple‐negative breast cancer	18
Non‐small cell lung carcinoma with focal coexpression of thyroid transcription factor‐1 and Δ Np63/p40: A case report	17
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A	17
Mixed micropapillary patterns found in malignant pleural mesothelioma with possibly worsened prognostic implication	17
Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study	17
PD‐1/PD‐L1 co‐location: A novel biomarker for immunotherapy response in non‐small cell lung cancer	17
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study	17
The regularity of anatomical variations of dominant pulmonary segments in the right upper lobe	16
Revisiting ALK (D5F3) immunohistochemistry: Insights into focal staining and neuroendocrine differentiation	16
An Innovative Management in the Diagnosis of Mediastinal Masses	16
Issue Information	16
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib	16
First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes	16
circFIG 4 drives the carcinogenesis and metastasis of esophagus cancer via the miR‐493‐5p/E2F3 axis	16
	15
Corrigendum	15
Response Letter to “Management of Chylothorax Following Thoracic Surgery” by Busetto et al.	15
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma	15
Potential activity of adiponectin‐expressing regulatory T cells against triple‐negative breast cancer cells through the cell‐in‐cell phenomenon	15
Issue Information	15
S‐ and R‐Carvedilol Prevent Benzo(a)pyrene‐Induced Lung Carcinogenesis	15
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients	15

KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway	15
Correction to “Stability and safety of transbronchial dye mixture for preoperative localization in a porcine model”	15
PICC Maintenance Challenges Among Esophageal Cancer Patients: A Qualitative Study	15
Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR‐6838‐5p	15
Circ_0011292 knockdown mitigates progression and drug resistance in PTX‐resistant non‐small‐cell lung cancer cells by regulating miR‐433‐3p/CHEK1 axis	14
Predicting visceral pleural invasion in lung adenocarcinoma presenting as part‐solid density utilizing a nomogram model combined with radiomics and clinical features	14
Everolimus in combination with octreotide LAR in thymic atypical carcinoid	14
Serum cross‐linked N‐telopeptide of type I collagen as a potential diagnostic marker for bone metastasis in lung cancer: An updated meta‐analysis	14
Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR‐330‐5p	14
Safety and feasibility of a novel chest tube placement in uniportal video‐assisted thoracoscopic surgery for non‐small cell lung cancer	14
There Is More Than Meets the Eye With Ground Glass Nodules: Is It Too Early to Adopt Sublobar Resection as Standard of Care for Early Stage Lung Adenocarcinoma?	14
Issue Information	14
A targeted siRNA‐loaded PDL1‐exosome and functional evaluation against lung cancer	14
The association of nutritional and inflammatory biomarkers with overall survival in patients with non‐small‐cell lung cancer treated with immune checkpoint inhibitors	14
Development of a deep learning‐based method to diagnose pulmonary ground‐glass nodules by sequential computed tomography imaging	14
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy	14
Issue Information	14
Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer	13
Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis	13
Issue Information	13
Second primary tumor after immune checkpoint inhibitor therapy: A case report	13
Association of Wearable Activity Monitors and Digital Drainage Device With Daily Ambulation and Length of Stay Among Pulmonary Resection Patients: A Prospective, Randomized Controlled Study	13
	13
Clinical Significance of Bone Metastases in Pleural Mesothelioma	13
Issue Information	13
	13
Issue Information	13
Issue Information	13
Correction to “Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Si	13
Issue Information	13
Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer (NSCLC) through apoptosis	13
Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy	13
Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR	12
Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis	12
Radiological and pathological analysis of the galaxy sign in patients with pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma	12
A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect	12
A case of concurrent follicular lymphoma and lung cancer requiring differentiation from lymph node metastasis	12
“Separated” precise subsegmentectomy: Single‐port thoracoscopic noncombined subsegmentectomy in one lung lobe	12
Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients	12
Mutations and expressions of breast cancer 1/2 in lung cancer	12
Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer	12
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer	12
A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy	12
Mucoepidermoid carcinoma cured by a combination of high‐frequency snare and photodynamic therapy: A case report	12
	12
Real‐World Evidence That Non‐Smokers With High PD‐L1 Non‐Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors	12
Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure	12
A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer	12
Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism	12
Nivolumab as maintenance therapy following platinum‐based chemotherapy in EGFR‐mutant lung cancer patients after tyrosine kinase inhibitor failure: A single‐arm, open‐label, phase 2	12
Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chem	12
Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion–insertion R) in an advanced non‐small cell lung cancer patient	12
Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective anal	12
Chronic obstructive pulmonary disease assessment test for the measurement of deterioration and recovery of health status of patients undergoing lung surgery	12
Resected stage I anaplastic lymphoma kinase‐positive lung adenocarcinoma has a negative impact on recurrence‐free survival	12
CORRECTION	11
	11
Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study	11
Ventilation challenge in rigid bronchoscopy: Laser tube as an alternative management in patients with lung cancer and central airway obstruction	11
Factors affecting long‐term survival of non‐small‐cell lung cancer patients with concomitant type 2 diabetes mellitus	11
Epithelial‐Mesenchymal Plasticity in the D‐Meso‐Sonobe Mesothelioma Cell Line: A Putative Model of Epithelial–Mesenchymal Transition in Mesothelioma	11
Bronchiolar adenoma/ciliated muconodular papillary tumor mixed with adenocarcinoma in situ in the same tumor	11
Multiple micromeningiomas coexist with primary lung adenocarcinoma: A case report	11
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma	11
Issue Information	11
Impact of Antibiotic on Efficacy and Adverse Reactions of Chemoimmunotherapy in Non‐small Cell Lung Cancer Patients: A Retrospective Cohort Study	11
	11
Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM?	11
	11
Chylothorax After Thoracic Surgery: How We Manage It	11
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma	11
Treatment and mortality risk of older adults with non‐small cell cancer in Taiwan: A population‐based cohort study	11
Impact of sarcopenia on the prognosis of patients with advanced non‐small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis	11
Circ_0003340 downregulation mitigates esophageal squamous cell carcinoma progression by targeting miR‐940/PRKAA1 axis	11
Issue Information	11
MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway	11
Examination of the effectiveness of local therapy for oligo‐recurrence of EGFR‐mutated NSCLC	11
Quantitative analysis of imaging characteristics in lung adenocarcinoma in situ using artificial intelligence	11
Issue Information	11
METTL3‐mediated the m6A modification of SF3B4 facilitates the development of non‐small cell lung cancer by enhancing LSM4 expression	11

Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma	11
The utility of bispectral index monitoring in flexible bronchoscopy: A single‐center, retrospective observational study	11
Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non‐small cell lung cancer	10
Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR‐622/SLC1A5 signaling axis	10
Early patient‐reported outcomes after robotic‐assisted versus video‐assisted thoracoscopic lobectomy	10
Short‐term safety of an anti‐severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs	10
Puncture frequency predicts pneumothorax in preoperative computed tomography‐guided lung nodule localization for video‐assisted thoracoscopic surgery	10
Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer	10
	10
The predictive value of the preoperative systemic immune‐inflammation index in the occurrence of postoperative pneumonia in non‐small cell lung cancer: A retrospective study base	10
Prognostic Impact of Tumor Solid Components in Stereotactic Body Radiotherapy for Clinical Stage Tis–1N0M0 Lung Cancer	10
	10
Circular RNA, circular RARS, promotes aerobic glycolysis of non‐small‐cell lung cancer by binding with LDHA	10
Update on therapeutic strategy for esophageal anastomotic leak: A systematic literature review	10
Tumor‐derived exosomal miR‐148b‐3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion	10
	10
The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma	10
USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2	10
Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non‐Small Cell Lung Cancer	10
Bronchiolar adenoma/ciliated muconodular papillary tumor complicated by lymphoid interstitial pneumonia in a patient with Sjögren's disease: A case report and systematic review	10
	10
Issue Information	10
Nondiagnostic, radial‐probe endobronchial ultrasound‐guided biopsy for peripheral lung lesions: The added value of radiomics from ultrasound imaging for predicting malignancy	10
Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens	10
The impact of COVID‐19 on new mesothelioma diagnoses in Italy	10
A propensity sore‐matched study: Applying a modified chest tube drainage strategy in rapid rehabilitation following uni‐portal thoracoscopic pulmonary wedge resection	10
Circulation of rare events in the liquid biopsy for early detection of lung mass lesions	10
Real‐World Analysis of Treatment Patterns in Limited‐Stage Small Cell Lung Cancer: Implications for Clinical Practice	10
Chinese expert consensus on cone‐beam CT‐guided diagnosis, localization and treatment for pulmonary nodules	10
Three‐dimensional lung reconstructions for the localization of lung nodules to be resected during surgery	10
Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient	10
	10
Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study	10
Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR‐136‐5p/YWHAZ axis	9
A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment	9
Synchronous resection of 12 small pulmonary nodules guided by a noninvasive 3D printed emulation model: A case report	9
Activation of circ_0072088/miR‐1261/PIK3CA pathway accelerates lung adenocarcinoma progression	9
SCLC and anti‐GABABR encephalitis: A retrospective analysis of 60 cases in China	9
Downregulation of PD‐L1 and HLA‐I in non‐small cell lung cancer with ALK fusion	9
Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease	9
Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma	9
Circ‐EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/β‐catenin pathway through the miR‐1253/NOVA2 axis	9
Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR‐mutated lung adenocarcinoma	9
Significance of Platinum‐Based Chemotherapy With Programmed Death‐1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study	9
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer	9
New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralate	9
Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy	9
Solitary extramedullary plasmacytoma of the left main bronchus: A case report and literature review	9
Division of the intersegmental demarcation using the “modified hand‐tearing method” is safe and feasible in thoracoscopic anatomical segmentectomy	9
Identification of the intersegmental plane via electromagnetic navigation for anatomical segmentectomy	9
Prognostic impact of tumor volume in patients with complete resection of thymoma	9
Factors affecting accuracy of clinical staging in resectable non‐small cell lung cancer in a real‐world study	9
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report	9
Mig‐6 could inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma	9
Long‐term stability of pleural fluid carcinoembryonic antigen and its effect on the diagnostic accuracy for malignant pleural effusion	9
	9
Lepidic growth component as a favorable prognostic factor in non–small cell lung cancer of ≤3 cm	9
GIMAP7 inhibits epithelial‐mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway	9
MiR‐379‐5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A	9
Liquid biopsy assay for pulmonary adenocarcinoma using supernatants from core‐needle biopsy specimens	9
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy	8
Comparing Needle and Surgical Biopsy in Small Peripheral Non‐Small Cell Lung Cancer With Suspected Pleural Invasion: A Propensity Score‐Matched Study	8
Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index	8
Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim	8
Circulating tumor DNA predicts the outcome of chemotherapy in patients with lung cancer	8
Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levels	8
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive‐stage small cell lung cancer (ES‐SCLC): Study protocol	8
Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non‐small cell lung cancers?	8
Issue Information	8
	8
Radiation‐induced pseudomembranous tracheobronchitis: A report of two cases	8
Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity	8
The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer	8
ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity	8
Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non‐small cell lung cancer	8
A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma	8
Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations	8
Nodule‐type pneumonitis mimicking lung abscess or tumor recurrence on chest computed tomography identified as osimertinib‐induced pneumonitis: A case report	8
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer	8
	8
	8
	8
Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β‐catenin pathway	8
The immune microenvironment of lung adenocarcinoma featured with ground‐glass nodules	8
Hyperprogression of a spindle‐cell squamous carcinoma of the esophagus after esophagectomy	8
Survival Outcome of Thoraco‐Laparoscopic McKeown Esophagectomy Versus Endoscopic Submucosal Dissection for Early‐Stage Esophageal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysi	8
Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma	8
Prophylactic cranial irradiation in patients with resected small‐cell lung cancer: A systematic review and meta‐analysis	8
The kinesin light chain‐2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC	8
Immune cell‐related prognostic risk model and tumor immune environment modulation in esophageal carcinoma based on single‐cell and bulk RNA sequencing	8
A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (st	8
Issue Information	8
Issue Information	8
	8
	8